Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Long-Term Cardiac Effects of Successful Non-Myeloablative HLA-Matched Sibling Transplants in Sickle Cell Disease

Vandana Sachdev, My-Le Nguyen, Wen Li, Neal Jeffries, Shalini S Ramachandra, David Tofovic, Damiano Rondelli, Matthew Hsieh, Santosh L. Saraf, Courtney D. Fitzhugh

Blood (2021) 138 (Supplement 1): 2898.

https://doi.org/10.1182/blood-2021-148173

Published: 2021

Journal Articles

NOVEL-1 st : A Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Hwang Wen-Li, MD, Tsung-Chih Chen, MD, Shyuann-Yuh Lin, MD, Ming-Chih Chang, MD, Pei-Ching Hsiao, MD, Li-Yuan Bai, PhD, Ching-Yuan Kuo, Yeu-Chin Chen, MD, Ta-Chih Liu, MD PhD, Jyh-Pyng Gau, MD, Po-Nan Wang, MD, Chieh-Wen Chen, Yee-Ming Lee, PhD, Fan-Chen Ku, MD, Jih-Luh Tang, MD, PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137327

Published: 2020

Journal Articles

A Machine Learning Algorithm to Improve Risk Assessment for Patients with Sickle Cell Disease

Vandana Sachdev, MD, Yuan Gu, PhD, James Nichols, RN, Wen Li, RCS, Stanislav Sidenko, RCS, Darlene Allen, MT(ASCP), Colin Wu, PhD, Swee Lay Thein, DSc, MBBS

Blood (2019) 134 (Supplement_1): 893.

https://doi.org/10.1182/blood-2019-125846

Published: 2019

Journal Articles

NOVEL-1 st : Interim Analysis of a Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Hwang Wen-Li, MD, Shao-Min Han, MD, Shyuann-Yuh Lin, MD, Ming-Chih Chang, MD, Li-Yuan Bai, PhD, Pei-Ching Hsiao, MD, Ching-Yuan Kuo, Yeu-Chin Chen, MD, Ta-Chih Liu, MD PhD, Po-Nan Wang, MD, Jyh-Pyng Gau, MD, Yee-Ming Lee, PhD, Fan-Chen Ku, Jih-Luh Tang, MD

Blood (2018) 132 (Supplement 1): 3019.

https://doi.org/10.1182/blood-2018-99-112342

Published: 2018

Journal Articles

Differential Impact of Conditioning Intensity on Post-Transplant Outcome of FLT3 -Mutated and FLT3 Wild Type AML in First Remission, a Report from Taiwan Bone Marrow Transplant Registry (TBMTR)

Su-Peng Yeh, MD, Ming Yao, MD, Jih-Luh Tang, MD,PhD, Jin-Hwang Liu, MD PhD, Tzeon-Jye Chiou, MD, Tran-Der Tan, Po-Nan Wang, MD, Yeu-Chin Chen, MD, Wen-Li Hwang, MD, Ciyuan-jheng Wang, MD, Tsai-Yun Chen, MD, TA-Chih LIU, MD PhD, Ming-Sun Yu, MD, Tso-Fu Wang

Blood (2017) 130 (Supplement 1): 3229.

https://doi.org/10.1182/blood.V130.Suppl_1.3229.3229

Published: 2017

Journal Articles

Response and Outcomes of Third-Line Tyrosine Kinase Inhibitor Therapy on Patients with Chronic Phase Chronic Myeloid Leukemia

Maliha Khan, Hagop M. Kantarjian, MD, Jing Ning, PhD, Mary Akosile, Wen Li, Gautam Borthakur, MD, Nitin Jain, MD, Courtney D. DiNardo, MDMSc, William G Wierda, MD PhD, Farhad Ravandi, MBBS, Guillermo Garcia-Manero, MD, Marina Konopleva, MD PhD, Tapan Kadia, MD, Naveen Pemmaraju, MD, Philip A Thompson, MBBS, Naval Daver, MD, Elias J. Jabbour, MD, Jorge E. Cortes, MD

Blood (2017) 130 (Supplement 1): 2882.

https://doi.org/10.1182/blood.V130.Suppl_1.2882.2882

Published: 2017

Journal Articles

Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study

Yi-Jiun Su, MD, Ming-Chung Kuo, MD, Chieh-Lin Teng, MD, Tsai-Yun Chen, MD, Ming-Chun Ma, MD, Pei-Ching Hsiao, MD, Ming-Chung Wang, MD, Tung-Huei Lin, MS, Wen-Li Hwang, MD, Chih-Cheng Chen, MD, Youngsen Yang, MD, Sung-Nan Pei, MD, Yen-Min Huang, MD, Sin-Syue Li, MD, Ming-Yang Lee, MD, Hung-I Cheng, MD, Lee-Yung Shih, MD

Blood (2017) 130 (Supplement 1): 1603.

https://doi.org/10.1182/blood.V130.Suppl_1.1603.1603

Published: 2017

Journal Articles

A Retrospective Multicenter Study to Evaluate the Efficacy of Rabbit Antithymocyte Globulin (rATG) Immunosuppressive Therapy As First-Line Treatment of Aplastic Anemia

Suporn Chuncharunee, MD, Raymond SM Wong, MD, Ponlapat Rojnuckarin, MD PhD, Cheng-Shyong Chang, MD, Kian Meng Chang, MD, Meng-Yao Lu, MD, Wen-Li Hwang, MD, Liang Piu Koh, MD, Tsai-Yun Chen, MD, Anskar YH Leung, MD, Lalita Norasetthada, MD, Shih-Chung Wang, MD, Ming-Chih Chang, MD, Kang-Hsi Wu, MD, Surapol Issaragrisil, MD

Blood (2015) 126 (23): 1217.

https://doi.org/10.1182/blood.V126.23.1217.1217

Published: 2015

Journal Articles

Safety and Efficacy of Nilotinib (NIL) in Patients (Pts) with Chronic Phase (CP) or Accelerated Phase (AP) Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML) with Resistance or Intolerance to Imatinib Mesylate (IM): Results from the Multicenter, Observational NOVEL Study in Taiwan

Ching-Yuan Kuo, MD, Po-Nan Wang, MD, Wen Li Hwang, MD, Cheng-Hwai Tzeng, MD, Li-Yuan Bai, MD, Jih-Luh Tang, MD PhD, Ming-Chih Chang, MD, Sheng-Fung Lin, MD, Tsai-Yun Chen, MD, Yeu-Chin Chen, MD, Tran-Der Tan, MD, Chih-Yi Hseih, MD, Chinjune Lin, MD, Miljkovic Darko, MD, Chang Cheng-Shyong, MD

Blood (2015) 126 (23): 1593.

https://doi.org/10.1182/blood.V126.23.1593.1593

Published: 2015

Journal Articles

No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study

Ming-Chung Kuo, MD, Tsai-Yun Chen, MD, Ming-Chung Wang, MD, Youngsen Yang, MD, Su-Peng Yeh, MD, Cheng-Shyong Chang, MD, Yii-Jenq Lan, MD, Chih-Cheng Chen, MD, Yu-Chieh Su, MD, Pei-Ching Hsiao, MD, Ching-Yuan Kuo, MD, Li-Yuan Bai, MD, Wen-Li Hwang, MD, Lee-Yung Shih, MD

Blood (2014) 124 (21): 4544.

https://doi.org/10.1182/blood.V124.21.4544.4544

Published: 2014

Journal Articles

The Outcome of Childhood Acute Lymphoblastic Leukemia with MLL Gene Rearrangement Treated with the Protocol (CCLG-ALL2008)

Yina SUN, Yi-huan Chai, MD, Hai-long He, MD, Jun LU, Yi WANG, Wen-li Zhao, Pei-fang Xiao, Jun-jie Fan, Shaoyan Hu, MD PhD

Blood (2014) 124 (21): 5243.

https://doi.org/10.1182/blood.V124.21.5243.5243

Published: 2014

Journal Articles

Phagocytosis by macrophages and endothelial cells inhibits procoagulant and fibrinolytic activity of acute promyelocytic leukemia cells

Rui Xie, Chunyan Gao, Wen Li, Jiuxin Zhu, Valerie Novakovic, Jing Wang, Ruishuang Ma, Jin Zhou, Gary E. Gilbert, Jialan Shi

Blood (2012) 119 (10): 2325–2334.

https://doi.org/10.1182/blood-2011-06-362186

Published: 2012

Journal Articles

Neutrophils Clearance by Endothelial Cells Regulates Homeostasis and Coagulation.

Wen Li, MD, Shuchuan Liu, MD, Yueyue Fu, MD, Jinxiao Hou, MD, Xiushuai Dong, MD, Rui Xie, MD, Xue Yang, MD, Chunyan Gao, MD, Jin Zhou, MD, PhD, Gary E. Gilbert, MD, Jialan Shi, MD, PhD

Blood (2010) 116 (21): 3782.

https://doi.org/10.1182/blood.V116.21.3782.3782

Published: 2010

Journal Articles

Daunorubicin Induces Procoagulant Activity of Cultured Endothelial Cells through Phosphatidylserine Exposure and Microparticles Release

Yueyue Fu, MD, Huibo Li, MD, Wen Li, MD, Xiushuai Dong, MD, Jinxiao Hou, MD, Rui Xie, MD, Chunyan Gao, MD, Xue Yang, MD, Jin Zhou, MD, PhD, Gary E. Gilbert, MD, Jialan Shi, MD, PhD

Blood (2010) 116 (21): 5185.

https://doi.org/10.1182/blood.V116.21.5185.5185

Published: 2010

Journal Articles

Lactadherin as a Probe for Phosphatidylserine Exposure and as An Anticoagulant for the Procoagulant Activity in the Study of Stored Platelets.

Jin Zhou, Jinxiao Hou, Wen Li, Xiaoqian Zhang, Yueyue Fu, Huibo Li, Rui Xie, Zhuo Zhang, Gary E. Gilbert, MD, Jialan Shi

Blood (2009) 114 (22): 3150.

https://doi.org/10.1182/blood.V114.22.3150.3150

Published: 2009

Journal Articles

Clinical Research of Autologous Hematopoietic Stem Cell Transplantation for Hematological Malignancies and Solid Tumors.

Zhen-qian Huang, Dong-hua Zhang, Huo Tan, Cheng-zhi Zhou, Dan Liu, Huan-zhu Zhang, Jie-xia Zhang, Wei Huang, Wen-li Liu

Blood (2005) 106 (11): 5475.

https://doi.org/10.1182/blood.V106.11.5475.5475

Published: 2005

NARROW

Long-Term Cardiac Effects of Successful Non-Myeloablative HLA-Matched Sibling Transplants in Sickle Cell Disease

NOVEL-1 st : A Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

A Machine Learning Algorithm to Improve Risk Assessment for Patients with Sickle Cell Disease

NOVEL-1 st : Interim Analysis of a Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan

Differential Impact of Conditioning Intensity on Post-Transplant Outcome of FLT3 -Mutated and FLT3 Wild Type AML in First Remission, a Report from Taiwan Bone Marrow Transplant Registry (TBMTR)

Response and Outcomes of Third-Line Tyrosine Kinase Inhibitor Therapy on Patients with Chronic Phase Chronic Myeloid Leukemia

Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study

A Retrospective Multicenter Study to Evaluate the Efficacy of Rabbit Antithymocyte Globulin (rATG) Immunosuppressive Therapy As First-Line Treatment of Aplastic Anemia

No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study

The Outcome of Childhood Acute Lymphoblastic Leukemia with MLL Gene Rearrangement Treated with the Protocol (CCLG-ALL2008)

Phagocytosis by macrophages and endothelial cells inhibits procoagulant and fibrinolytic activity of acute promyelocytic leukemia cells

Neutrophils Clearance by Endothelial Cells Regulates Homeostasis and Coagulation.

Daunorubicin Induces Procoagulant Activity of Cultured Endothelial Cells through Phosphatidylserine Exposure and Microparticles Release

Lactadherin as a Probe for Phosphatidylserine Exposure and as An Anticoagulant for the Procoagulant Activity in the Study of Stored Platelets.

Clinical Research of Autologous Hematopoietic Stem Cell Transplantation for Hematological Malignancies and Solid Tumors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only